leucovorin calcium / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 424 Diseases   807 Trials   807 Trials   14372 News 
1048 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
leucovorin calcium / Generic mfg.
ChiCTR-RCH-11001176: Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC

Completed
4
200
 
FOLFIRI based chemotherapy
Tongji Hospital of Tongji Medical College, Hua Zhong University of Science & Technology; Pfizer Pharmaceuticals Limited, Pfizer Pharmaceuticals Limited
colorectal cancer
 
 
ChiCTR-TNC-11001535: Selection of gene to predict disease or guide prognosis in advanded/relapsed colorectal cancer with FOLFIRI as first-line therapy

Recruiting
4
100
 
CPT-11, 5-Fu
Henan cancer hospital affiliated to Zhengzhou university; Level of the institution：, NA
colorectal cancer
 
 
ChiCTR-ONC-13004542: The clinical research about Joint detection of toxicity and efficacy related marker of chemotherapy drug in individual therapy of colorectal cancer

Recruiting
4
300
 
FOLFIRI方案
Sichuan Cancer Hospital; Sichuan Cancer Hospital, Pfizer sponsored
colorectal cancer
 
 
ChiCTR-TRC-10000961: Oxaliplatin combinating 5-fluorouracil and calcium folinic Acid Adjuvant chemotherapy after liver transplantation for hepatocellular carcinoma patients who do not meet Milan criteria

Completed
4
60
 
Adjuvant chemotherapy after liver transplantation
General Hospital of Chinese People's Armed Police Force; Level of the institution：, General Hospital of Chinese People’s Armed Police Force
hepatocellular carcinoma (HCC)
 
 
XQZL001, ChiCTR-ONC-13004323: A single arm trial of cetuximab, FOLFIRI combined with NK as the second line region in metastatic K-ras positive colorectal cancer: the study

Completed
4
30
 
cetuximab, FOLFIRI combined with NK as the second line remedy
the Affiliated Xinqiao Hospital of the Third Military Medical University; Level of the institution：, Affiliated Xinqiao Hospital of the Third Military Medical University, Chongqing, P.R.China
colorectal cancer
 
 
2007-006748-23: Tratamiento con ácido fólico en pacientes con defectos de la fosforilización oxidativa mitocondrial.TREATMENT WITH FOLINIC ACID IN PATIENTS WITH TROUBLES OF MITOCHONDRIAL OXIDATIVE FOSFORILATION.

Ongoing
4
30
Europe
Acido fólico LEDERFOLIN, LEDERFOLIN, LEDERFOLIN
HOSPITAL SANT JOAN DE DÉU
tratamiento del défivcit de ácido folínico cerebral por defectos de la fosforilación oxidativa mitocondrial.
 
 
2010-019885-10: The purpose of this interventional study is to assess the progression free survival (one year) of patients with treatment of FOLFIRI and cetuximab, combined with an optional dermal prophylaxis.

Ongoing
4
165
Europe
Cetuximab, Erbitux® 5mg/ml concentrate for solution for infusion, Erbitux® 5mg/ml concentrate for solution for infusion
Universitätsmedizin Mainz (vertreten durch den wissenschaftlichen Vorstand), MerckSerono GmbH, Universitätsmedizin Mainz
metastatic colorectal cancer (mCRC)
 
 
2017-003509-16: Serum cytokine levels as predictors of the efficacy of aflibercept in combination with FOLFIRI in metastatic Colo-Rectal Cancer patients (mCRC) Livelli sierici di citochine come predittori di efficacia di aflibercept in combinazione con FOLFIRI in pazienti con Cancro al Colon-Retto metastatico

Ongoing
4
124
Europe
Concentrate for solution for infusion, ZALTRAP - 25 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONE (VETRO) - 100 MG/4 ML - 1 FLACONE
FONDAZIONE RICERCA TRASLAZIONALE (FORT), Sanofi S.p.A.
Metastatic Colo-Rectal Cancer Cancro al Colon-Retto metastatico, Metastatic Colo-Rectal Cancer Cancro al Colon-Retto metastatico, Diseases [C] - Cancer [C04]
 
 
ChiCTR-OPC-17010714: Apatinib Mesylate Tablets of joint mFOLFOX6 neoadjuant chemotherapy in locally advanced colorectal cancer clinical research

Recruiting
4
60
 
Apatinib Mesylate Tablets of joint mFOLFOX6 neoadjuant chemotherapy
Tianjin people's hospital; Tianjin people's hospital, Jiang Su Heng Rui medicine. co.LTD
Colorectal cancer
 
 
ChiCTR1800015308: A multi-center single arm study of FOLFIRI combined with Apatinib on the treatment of non resectable metastatic colorectal cancer

Recruiting
4
40
 
FOLFIRI combined with apatinib
Shanxi Tumor Hospital; Shanxi Tumor Hospital, Chinese Anti-Cancer Association- HengRui pharmaceutical innovative medicine clinical research fund
advanced colorectal cancer
 
 
2018-004231-72: Randomized study of the detection of mutations by BEAMing technology in advance of the radiological diagnosis of progression in patients with metastatic colorectal cancer and primary tumor in the left colon / rectum Estudio aleatorizado de la detección de mutaciones por tecnología BEAMing de forma anticipada al diagnóstico radiológico de la progresión en pacientes con cáncer colorrectal metastásico y tumor primario en el colon izquierdo/recto

Ongoing
4
80
Europe
Calcium Folinate, cetuximab, Hidrocloruro de irinotecán trihidrato, Oxaliplatino, panitumumab, L01XC06, , Solution for solution for injection, Solution for infusion, 5-Fluorouracilo, Calcium Folinate, Erbitux, Irinotecán, Oxaliplatino Teva, Vectibix
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS), Oncology Department
Median of the progression-free survival of patients with mCRC who maintains the treatment in conventional 1st line, QT + anti-EFGR, versus patients who withdraw anti-EGFR therapy after detection of mutations of the RAS gene / BRAF through the OncoBEAM ™ test. Comparar la mediana de supervivencia libre de progresión de pacientes con CCRm que mantienen el tratamiento en 1º línea convencional, QT + anti-EFGR, frente a la de los pacientes a los que se retira la terapia anti-EGFR tras la detección de mutaciones del gen RAS/BRAF mediante el test OncoBEAM™., Patients with colon-rectal cancer, primary tumor in left / rectum colon. Pacientes con Cáncer colo-rectal, tumor primario en colon izquierdo/recto., Diseases [C] - Cancer [C04]
 
 
BeFoLMe study, ChiCTR-IPR-17013973: The effect of Metformin combine with FOLFOX + Bevacizumab as the first-line therapy in metastatic colorectal cancer, a randomized, open, prospective clinical study

Not yet recruiting
4
40
 
Metformin 250mg per day combine with FOLFOX + Bevacizumab ;FOLFOX + Bevacizumab
Xiangya Hospital, Central South University; Xiangya Hospital, Central South University, Xiangya Hospital, Central South University
Colorectal Cancer
 
 
ChiCTR1800014964: A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer

Not yet recruiting
4
40
 
Mesylate Apatinib
Affiliated Tumor Hospital of GuangXi Medical University; Level of the institution：, self-raised
colorectal cancer
 
 
ChiCTR1800019212: A prospective, open-label clinical study for apatinib combined with mFOLFOX6 chemotherapy in the treatment of postoperative colorectal cancer

Not yet recruiting
4
50
 
apatinib combined with mFOLFOX6 chemotherapy
The Second Affiliated Hospital of Chongqing Medical University; The Second Affiliated Hospital of Chongqing Medical University, Jiangsu hengrui pharmaceutical co. LTD
colorectal cancer
 
 
ChiCTR2000034870: A prospective, randomized controlled study of mFOLFIRINOX versus gemcitabine combined with albumin paclitaxel in the treatment of patients with unresectable pancreatic cancer

Recruiting
4
200
 
Oxaliplatin: 85 mg/m2, intravenous infusion, day 1; leucovorin: 400 mg/m2, intravenous infusion, day 1; irinotecan: 150 mg/m2 , Intravenous infusion, day 1; bolus injection of 5-FU: 2400 mg/m2, intravenous infusion, 46 hours; once every two weeks ;Albumin paclitaxel (nab-paclitaxel): 125mg/m2, intravenous infusion (30 minutes), on day 1, 8; gemcitabine (GEM): 1000 mg/m2, intravenous infusion, on day 1, 8; Once every three weeks
Wannan Medical College; Wannan Medical College, Self-financing
Pancreatic cancer
 
 
TROJAN 021, ChiCTR1900027922: Clinical study for efficacy and safety of Oncorine (Recombinant Human Adenovirus Type 5 Injection) combined with mFOLFOX6+ bevacizumab in the treatment of unresectable colorectal adenocarcinoma with liver metastases

Recruiting
4
210
 
Oncorine+ mFOLFOX6 + bevacizumab ;mFOLFOX6 + bevacizumab
Shanghai Tenth People's Hospital; Shanghai Tenth People's Hospital, Shanghai Science and Technology Commission/Shanghai Sunway Biotech Co., Ltd
Unresectable colorectal adenocarcinoma liver metastasis
 
 
ChiCTR1800014879: Study on antiangiogenic transformation medicine of advanced colorectal cancer based on APE1 expression

Not yet recruiting
4
116
 
Endostar combined with FOLFOX ;FOLFOX
Daping Hospital, Chongqing; Daping Hospital，Chongqing, Project funding
Colorectal cancer
 
 
ChiCTR2000030610: Anti-PD-1 Antibody Carrizumab combined with FLOT versus FLOT in neoadjuvant treatment of gastric or gastroesophageal junction adenocarcinoma: a randomized, single-center and controlled trial

Not yet recruiting
4
60
 
Carrizumab + docetaxel + oxaliplatin + calcium folinate + fluorouracil ;docetaxel + oxaliplatin + calcium folinate + fluorouracil
The Affiliated Hospital of Qingdao University; The Affiliated Hospital of Qingdao University, self-financing
gastric or gastroesophageal junction adenocarcinoma
 
 
ChiCTR-IPR-15007509: The clinical randomized trial of adjuvant chemotherapy with FOLFOX to reduce the recurrence in HCC patients at high risk after resection

Recruiting
4
290
 
Adjuvant therapy 8~12 cycles with FOLFOX ;Regular follow-up
Cancer Center of SUN Yat-sen University; Cancer Center of SUN Yat-sen University, The clinical research fund of Cancer Center of SUN Yat-sen University (308 project)
Hepatocellular carcinoma
 
 
ChiCTR2100050018: Leucovorin for the Treatment in Children With Autism Spectrum Disorder : an open label clinical study

Recruiting
4
66
 
Oral Leucovorin 2mg / (kg. D) + comprehensive rehabilitation training for 12 weeks ;Comprehensive rehabilitation training for 12 weeks
Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-Sen University; Maternity and Children Health Care Hospital of Luohu, Luohu District soft science research Foundation
Autism spectrum disorder
 
 
ChiCTR2100045971: Camrelizumab and FOLFOX chemotherapy by hepatic artery infusion combined with apatinib mesylate treat the first-line of advanced unresectable hepatocellular carcinoma, an open, prospective, single-center clinical study

Recruiting
4
20
 
Camrelizumab and FOLFOX chemotherapy by hepatic artery infusion combined with apatinib mesylate
The First Affiliated Hospital of Nanyang Medical College; The First Affiliated Hospital of Nanyang Medical College, Self-funded
Liver Cancer
 
 
ChiCTR2000033603: Toripalimab combined with Cetuximab and FOLFIRI for first-line treatment of metastatic unresectable left side, KRAS/NRAS/BRAF wild-type advanced colorectal cancer: a single-arm, open, multicenter clinical study

Recruiting
4
61
China
Toripalimab combined with Cetuximab and FOLFIRI
Jiangsu Cancer Hospital ; Jiangsu Cancer Hospital, self-financing
Colorectal cancer
 
 
ChiCTR2000037711: A Multicenter Prospective Clinical Trial: Conversion Therapy for RAS/BRAF Wild-Type Right-Sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Recruiting
4
520
 
FOLFOXIRI plus Cetuximab ;FOLFOXIRI plus Bevacizumab
Fudan University Zhongshan Hospital; Fudan University Zhongshan Hospital, Shanghai Shenkang Hospital Development Center; raise independently
colorectal cancer
 
 
IMPROVE-I, NCT03656549: Dose Individualization of Pemetrexed -

Completed
4
6
Europe
Pemetrexed + oral folinic acid rescue
Radboud University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development
Non Small Cell Lung Cancer, Mesothelioma
12/23
12/23
FLEX, NCT06010277: Folinic Acid for Prevention of Pemetrexed-induced Toxicity

Recruiting
4
50
Europe
Folinic acid
Amphia Hospital, Albert Schweitzer Hospital
NSCLC, Mesothelioma, Thymoma
01/24
01/24
NCT06269445: The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer

Recruiting
4
20
RoW
Icaritin Combined With Bevacizumab and FOLFIRI
Sir Run Run Shaw Hospital
Colorectal Cancer
02/25
02/26
NCT02366819: Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Recruiting
4
36
US
Oxaliplatin, Leucovorin Calcium, CF, Irinotecan Hydrochloride, Fluorouracil, Conventional Surgery, surgery, conventional
University of Chicago, National Cancer Institute (NCI)
Esophageal Adenocarcinoma, Gastric Adenocarcinoma, Stage IIB Gastric Cancer, Stage IIIA Esophageal Adenocarcinoma, Stage IIIA Gastric Cancer, Stage IIIB Esophageal Adenocarcinoma, Stage IIIB Gastric Cancer, Stage IIIC Esophageal Adenocarcinoma, Stage IIIC Gastric Cancer
06/25
06/25
NCT05124002: Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma

Recruiting
4
66
RoW
Recombinant Human Adenovirus Type 5, H101, HAIC of FOLFOX, FOLFOX
Beijing Tsinghua Chang Gung Hospital
Cholangiocarcinoma, Intrahepatic
04/26
04/26
ChiCTR2200062214: A Prospective, Single-arm, Multicenter Clinical Study of Hepatic Arterial Infusion Chemotherapy Combined with Carrelizumab and Apatinib in the Treatment of Potentially Resectable Primary Hepatocellular Carcinoma

Not yet recruiting
4
30
 
Hepatic Arterial Infusion Chemotherapy (FOLFOX) Combined with Carrelizumab Combined with Apatinib
The First Hospital of China Medical University; The First Hospital of China Medical University, Jiangsu Hengrui Medicine Co., Ltd.
Liver cancer
 
 
ChiCTR2200062213: A prospective, single-arm, multicenter clinical study of transcatheter arterial infusion chemotherapy combined with carrelizumab and apatinib in the treatment of primary liver cancer with main trunk tumor thrombus

Not yet recruiting
4
34
 
Hepatic arterial infusion chemotherapy (FOLFOX) combined with camrelizumab and apatinib
The First Hospital of China Medical University; The First Hospital of China Medical University, Jiangsu Hengrui Pharmaceutical Co., Ltd.
liver cancer
 
 
CRC - PTX, NCT06115174: Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer

Not yet recruiting
4
44
NA
Pentoxifylline, FOLFOX, XELOX, Monoclonal antibodies (target therapy)
Tanta University
Metastatic Colorectal Carcinoma
11/24
12/24
NCT04810585: Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer

Recruiting
4
153
RoW
Aflibercept + FOLFIRI
Yonsei University
Recurrent or Metastatic Colorectal Cancer
10/25
10/25
NCT00004317: Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

Recruiting
4
600
US
Leucovorin calcium, Pyrimethamine, Spiramycin, Sulfadiazine
National Institute of Allergy and Infectious Diseases (NIAID), University of Chicago
Toxoplasmosis
12/30
12/30
PMID18349393: Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin

Completed
3
220
Germany
5-fluorouracil - Generic mfg., leucovorin calcium - Generic mfg., oxaliplatin - Generic mfg.
Krankenhaus Nordwest
previously untreated advanced adenocarcinoma of the stomach or esophagogastric junction
 
 
BICC-C: Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer

Completed
3
430
US
5-fluorouracil - Generic mfg., leucovorin calcium - Generic mfg., irinotecan - Generic mfg., capecitabine - Generic mfg., celecoxib oral - Generic mfg.
Dana-Farber Cancer Institute
Colorectal Cancer
 
 
Eagle, UMIN000002557: Multicenter randomized phase III study of adding Bevacizumab 5mg/kg or 10mg/kg to FOLFIRI in advanced colorectal cancer who have failed prior Bevacizumab plus Oxaliplatin-based therapy.

Completed
3
370
Japan
Avastin (bevacizumab) - Roche, 5-fluorouracil - Generic mfg., irinotecan - Generic mfg., leucovorin calcium - Generic mfg.
Epidemiological and Clinical research Information Network (ECRIN), Epidemiological and Clinical research Information Network (ECRIN)
Colorectal Cancer
 
 
ACTRN12624000005550: Neoadjuvant chemotherapy in resectable pancreatic cancer

Recruiting
3
100
 
Epworth HealthCare, Epworth HealthCare
Pancreatic cancer
 
 
ChiCTR-TRC-12002734: S-1 plus oxaliplatin (SOX) versus fluorouracil and folinic acid plus oxaliplatin (mFOLFOX6) for first-line treatment of patients with metastatic colorectal cancer: a randomised controlled trial

Completed
3
360
 
S-1 plus oxaliplatin ;fluorouracil and folinic acid plus oxaliplatin
West China Hospital, Sichuan University; Shandong New Time（age） Pharmaceutical Co., LTD, Shandong New Time (age) Pharmaceutical Co., LTD
Shandong New Time (age) Pharmaceutical Co., LTD
 
 
S8899, SWOG-8899: A Prospectively Randomized Trial of Low-Dose Leucovorin Plus 5-FU, High-Dose Leucovorin Plus 5-FU, Levamisole Plus 5-FU, or Low-Dose Leucovorin Plus 5-FU Plus Levamisole Following Curative Resection

Completed
3
3
Philadelphia, PA, US
leucovorin calcium - Generic mfg., 5-fluorouracil - Generic mfg., levamisole - Generic mfg.
University of Pennsylvania
Duke's B or C Colon Cancer;high-risk stage II and III colon cancer
 
 
S9008, SWOG-9008: Trial of Adjuvant Chemoradiation After Gastric Resection For Adenocarcinoma, Phase III

Completed
3
559
US
5-fluorouracil - Generic mfg., leucovorin calcium - Generic mfg.
Radiation Oncology Center of Olathe
Gastrointestinal Cancer
 
 
NCT00004034: Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia

Active, not recruiting
3
420
US, Canada
asparaginase, cytarabine, dexrazoxane hydrochloride, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, methylprednisolone, prednisolone, prednisone, therapeutic hydrocortisone, vincristine sulfate, quality-of-life assessment, radiation therapy
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Cardiac Toxicity, Leukemia
 
 
2011-005003-32: A study comparing the effect of chemotherapy with the effect of chemotherapy plus local removal of metastases for patients with cancer of the large bowel which has spread to multiple organs.

Ongoing
3
478
Europe
capecitabin, oxaliplatin, bevacizumab, fluorouracil, Folinic acid, Film-coated tablet, Concentrate for solution for infusion, Concentrate for solution for injection/infusion, Solution for injection/infusion, Xeloda, Eloxatin, Avastin, Fluorouracil, Sodiofolin
VU University Medical Center, Department of Medical Oncology, VU University Medical Center, Department of Medical Oncology
multi-organ metastatic colorectal cancer, Patients with metastases of large bowel cancer in multiple organs, Diseases [C] - Cancer [C04]
 
 
2013-003244-23: Study evaluating, as first-line treatment of metastatic colorectal cancer, Bevacizumab +FOLFIRI followed by Bevacizumab + FOLFOX( or XELOX) or the reverse sequence Bevacizumab + FOLFOX (or XELOX) folloewed by Bevacizumab + FOLFIRI versus the standard Bevacizumab+ FOLFIRI Studio che mette a confronto, come trattamento di prima linea del tumore metastatico del colon-retto, il Bevacizumab + FOLFIRI seguito da Bevacizumab + FOLFOX (o XELOX) oppure la squenza inversa Bevacizumab + FOLFOX ( o XELOX) seguito da Bevacizumab + FOLFIRI contro la terapia standard che prevde Bevacizumab + FOLFIRI.

Ongoing
3
400
Europe
Concentrate for solution for infusion, Film-coated tablet, Solution for infusion, Powder for infusion, Avastin, CAMPTO, OXALIPLATINO, XELODA, FLUOROURACILE TEVA, LEVOFOLENE
S.I.C.O.G. ONLUS, S.I.C.O.G. ONLUS
Unresectable and metastatic colorectal cancer carcinoma del colon-retto inoperabile e metastatico, Advanced tumour of colon/rectum Tumore avanzato del colon-retto, Diseases [C] - Cancer [C04]
 
 
2014-004436-19: Phase III study to compare two different chemotherapy treatments to determine whether the first line with the three drugs + bevacizumab followed by a second line with the same regimen may provide better results than treatment with two drugs + bevacizumab is the first and the second treatment line Studio di fase III per confrontare due diversi trattamenti chemioterapici per valutare se la prima linea con tre farmaci + bevacizumab seguita da una seconda linea con lo stesso schema terapeutico possa fornire risultati migliori rispetto a un trattamento con due farmaci + bevacizumab sia nella prima che nella seconda linea di trattamento

Ongoing
3
654
Europe
Bevacizumab, 5 Fluorouracile, Irinotecan, Oxaliplatino, acido levo-folinico (L-Leucovorin), Bevacizumab, 5 Fluorouracile, Irinotecan, Oxaliplatino, acido levo-folinico (L-Leucovorin), Concentrate for solution for infusion, Solution for infusion, Powder for solution for infusion, Avastin, FLUOROURACILE TEVA* 500mg/10 ml, IRINOTECAN TEVA* 20 mg/ml, OXALIPLATINO TEVA* 5 mg/ml, LEDERFOLIN PFIZER* 25 mg
G.O.N.O., Roche S.p.A.
METASTATIC COLORECTAL CANCER Carcinoma colorettale metastatico (mCRC), metastatic tumor of colon-rectum, Diseases [C] - Cancer [C04]
 
 
2013-003047-29: BALLAD UK- a trial to evaluate the potential benefit of adjuvant chemotherapy for small bowel adenocarcinoma

Ongoing
3
120
Europe
Fluorouracil, Folinic Acid, Capecitabine, Oxaliplatin, Solution for injection/infusion, Film-coated tablet, Solution for infusion
Greater Glasgow and Clyde Health Board, University of Glasgow, CRUK
Small Bowel Adenocarcinoma, Small Bowel Adenocarcinoma, Diseases [C] - Cancer [C04]
 
 
2005-000686-19: PACT (Patient Preferences in Adjuvant Colorectal Cancer Therapy) - A randomised crossover clinical trial comparing Bolus Fluorouracil/Leucovorin to Capecitabine as treatment for moderate to high risk resected colorectal cancer

Ongoing
3
74
Europe
Xeloda, Xeloda, 5-fluorouracil, Leucovorin, Xeloda, 5-fluorouracil, Leucovorin
University of Leeds
Moderate to high risk resected colorectal cancer
 
 
ChiCTR-TRC-13003504: Capecitabine as maintenance chemotherapy in advanced colorectal cancer

Recruiting
3
300
 
Maintain with capecitabine after XELOX or FOLFOX treatment ;XELOX or FOLFOX
West China Hospital，Sichuan University; West China Hospital，Sichuan University, No-funds
advanced colorectal cancer
 
 
acns0333, NCT00653068: Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

Completed
3
70
Canada, US, RoW
3-Dimensional Conformal Radiation Therapy, 3-dimensional radiation therapy, 3D Conformal, 3D CONFORMAL RADIATION THERAPY, 3D CRT, 3D radiotherapy, 3D-CRT, Conformal Therapy, Radiation Conformal Therapy, Radiation, 3D Conformal, Three dimensional external beam radiation therapy (procedure), Autologous Hematopoietic Stem Cell Transplantation, AHSCT, Autologous, Autologous Hematopoietic Cell Transplantation, Autologous Stem Cell Transplant, Autologous Stem Cell Transplantation, Stem Cell Transplantation, Autologous, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B-518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, WR-138719, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP16, Filgrastim, Filgrastim Biosimilar Filgrastim-sndz, Filgrastim Biosimilar Tbo-filgrastim, Filgrastim XM02, Filgrastim-aafi, Filgrastim-ayow, Filgrastim-sndz, G-CSF, Granix, Neupogen, Neutroval, Nivestym, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, Releuko, rG-CSF, Tbo-filgrastim, Tevagrastim, XM02, Zarxio, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, Folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Thiotepa, 1,1',1''-Phosphinothioylidynetrisaziridine, Girostan, N,N', N''-Triethylenethiophosphoramide, Oncotiotepa, STEPA, Tepadina, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
Children's Oncology Group, National Cancer Institute (NCI)
Childhood Atypical Teratoid/Rhabdoid Tumor
09/16
03/24
2016-002331-16: Comparaison d'un traitement par FOLFOX (Oxaliplatine et 5 FU) et du traitement par TFOX (oxaliplatine + 5 FU et Docetaxel) chez les patients ayant un cancer de l'estomac ou de la jonction entre estomac et oesophage localement avancé ou métastatique

Not yet recruiting
3
506
Europe
Solution for infusion, TAXOTERE
Fédération Francophone de Cancérologie Digestive, Fédération Francophone de Cancérologie Digestive
Cancer de l'estomac et de la jonction oeso-gastrique localement avancé ou métastatique, Patient présentant un cancer de l'estomac ou de la jonction estomac-oesophage localement avancé ou avec des métastases, Diseases [C] - Cancer [C04]
 
 
COG-ACNS0334, NCT00336024: Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

Active, not recruiting
3
91
Canada, US, RoW
Autologous Hematopoietic Stem Cell Transplantation, AHSCT, Autologous, Autologous Hematopoietic Cell Transplantation, Autologous Stem Cell Transplant, Autologous Stem Cell Transplantation, Stem Cell Transplantation, Autologous, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Filgrastim, Filgrastim Biosimilar Filgrastim-sndz, Filgrastim Biosimilar Tbo-filgrastim, Filgrastim XM02, Filgrastim-aafi, Filgrastim-ayow, Filgrastim-sndz, G-CSF, Granix, Neupogen, Neutroval, Nivestim, Nivestym, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, Releuko, rG-CSF, Tbo-filgrastim, Tevagrastim, XM02, Zarxio, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Quality-of-Life Assessment, Quality of Life Assessment, Thiotepa, 1,1',1''-Phosphinothioylidynetrisaziridine, Girostan, N,N', N''-Triethylenethiophosphoramide, Oncotiotepa, SH 105, SH-105, SH105, STEPA, Tepadina, Tepylute, TESPA, Tespamin, Tespamine, Thio-Tepa, Thiofosfamide, Thiofozil, Thiophosphamide, Thiophosphoamide, Thiophosphoramide, Thiotef, Tifosyl, TIO TEF, Tio-tef, Triethylene Thiophosphoramide, Triethylenethiophosphoramide, Tris(1-aziridinyl)phosphine sulfide, TSPA, WR 45312, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
Children's Oncology Group, National Cancer Institute (NCI)
Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
12/16
12/28
2016-004394-40: FOLFOXIRI plus Panitumumab or FOLFOX plus Panitumumab in the treatment of metastatic colorectal cancer. folfoxiri più panitumumab contro folfox più panitumumab nel carcinoma del colonretto metastatico.

Ongoing
3
432
Europe
Panitumumab, Fluorouracile, Oxaliplatino, Calcio Levofolinato, Irinotecan, [Panitumumab], [Fluorouracile], [Oxaliplatino], [Calcio Levofolinato], [Irinotecan], Solution for infusion, VECTIBIX - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO 1 FLACONCINO (VETRO) 20 ML, FLUOROURACILE AHCL - 50MG/ML SOLUZIONE INIETTABILE O INFUSIONE 1 FLACONCINO IN VETRO DA 100 ML, OXALIPLATINO ACCORD - 5 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FLACONCINO IN VETRO DA 40 ML, CALCIO LEVOFOLINATO TEVA - 25 MG POLVERE PER SOLUZIONE INIETTABILE 1 FLACONCINO, IRINOTECAN CSC - 20 MG/ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FLACONCINO IN VETRO DA 15 ML
Fondazione GONO, Amgen, G.O.N.O.
Metastatic Colorectal Cancer Carcinoma Colorettale metastatico, colorectal cancer spread at distance tumore al colon retto diffuso a distanza, Diseases [C] - Cancer [C04]
 
 
AALL0434, NCT00408005: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

Active, not recruiting
3
1895
Europe, Canada, US, RoW
Asparaginase, ASP-1, Asparaginase II, Asparaginase-E.Coli, Colaspase, Elspar, Kidrolase, L-Asnase, L-ASP, L-Asparaginase, L-Asparagine Amidohydrolase, Laspar, Lcf-ASP, Leucogen, Leunase, MK-965, Paronal, Re-82-TAD-15, Serasa, Spectrila, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Daunorubicin Hydrochloride, Cerubidin, Cerubidine, Cloridrato de Daunorubicina, Daunoblastin, Daunoblastina, Daunoblastine, Daunomycin Hydrochloride, Daunomycin, hydrochloride, Daunorubicin.HCl, Daunorubicini Hydrochloridum, FI-6339, Ondena, RP-13057, Rubidomycin Hydrochloride, Rubilem, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, LenaDex, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, FI106, hydroxydaunorubicin, Rubex, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, Bw 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Jylamvo, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Nelarabine, 2-Amino-6-methoxypurine arabinoside, 506U78, Arranon, Compound 506U78, GW506U78, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Thioguanine, 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Aminopurine-6-thiol Hemihydrate, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Thioguanine Hemihydrate, Thioguanine Hydrate, Tioguanin, Tioguanine, Wellcome U3B, WR-1141, X 27, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
09/17
03/25
AALL0631, NCT00557193: Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
3
218
Canada, US, RoW
Asparaginase, ASP-1, Asparaginase II, Asparaginase-E.Coli, Colaspase, Elspar, Kidrolase, L-Asnase, L-ASP, L-Asparaginase, L-Asparagine Amidohydrolase, Laspar, Lcf-ASP, Leucogen, Leunase, MK-965, Paronal, Re-82-TAD-15, Serasa, Spectrila, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Bone Marrow Biopsy, Biopsy of Bone Marrow, Biopsy, Bone Marrow, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Daunorubicin Hydrochloride, Cerubidin, Cerubidine, Cloridrato de Daunorubicina, Daunoblastin, Daunoblastina, Daunoblastine, Daunomycin Hydrochloride, Daunomycin, hydrochloride, Daunorubicin.HCl, Daunorubicini Hydrochloridum, FI-6339, Ondena, RP-13057, Rubidomycin Hydrochloride, Rubilem, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, LenaDex, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Echocardiography, EC, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Filgrastim, Filgrastim Biosimilar Filgrastim-sndz, Filgrastim Biosimilar Tbo-filgrastim, Filgrastim XM02, Filgrastim-aafi, Filgrastim-ayow, Filgrastim-sndz, G-CSF, Granix, Neupogen, Neutroval, Nivestim, Nivestym, r-metHuG-CSF, Recombinant Methionyl Human Granulocyte Colony Stimulating Factor, Releuko, rG-CSF, Tbo-filgrastim, Tevagrastim, XM02, Zarxio, Laboratory Biomarker Analysis, Lestaurtinib, CEP 701, CEP-701, CEP701, KT-5555, SPM-924, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, Bw 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Methylprednisolone, Adlone, Caberdelta M, DepMedalone, Depo Moderin, Depo-Nisolone, Duralone, Emmetipi, Esametone, Firmacort, Medlone 21, Medrate, Medrol, Medrol Veriderm, Medrone, Mega-Star, Meprolone, Methylprednisolonum, Metilbetasone Solubile, Metrocort, Metypresol, Metysolon, Predni-M-Tablinen, Prednilen, Radilem, Sieropresol, Solpredone, Summicort, Urbason, Veriderm Medrol, Wyacort, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Pharmacological Study, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Therapeutic Hydrocortisone, Aeroseb-HC, Barseb HC, Barseb-HC, Cetacort, Cort-Dome, Cortef, Cortenema, Cortifan, Cortisol, Cortispray, Cortril, Dermacort, Domolene, Eldecort, Hautosone, Heb-Cort, Hydrocortisone, Hydrocortone, Hytone, Komed-HC, Nutracort, Proctocort, Rectoid, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
Children's Oncology Group, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia
09/17
06/24
2017-002036-17: The (cost)effectiveness of preoperative chemotherapy versus preoperative gemcitabine based chemoradiotherapy and adjuvant gemcitabine in patients with pancreatic cancer.

Ongoing
3
368
Europe
Leucovorin calcium, Fluorouracil, Irinotecan, Oxaliplatin, Powder for solution for injection/infusion, Solution for infusion, Concentrate for solution for infusion, LEUCOVORIN CALCIUM, Fluorouracil, Irinotecan, Oxaliplatin
Erasmus Medical Center, ZonMw, KWF
(borderline) resectable pancreatic cancer, (possible) resectable pancreatic cancer, Diseases [C] - Cancer [C04]
 
 
2018-000377-68: Treatment for Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Ongoing
3
218
Europe
Paclitaxel in cationic liposomes, EndoTAG-1, Powder and solvent for concentrate for solution for infusion
SynCore Biotechnology Co., Ltd., SynCore Biotechnology Co., Ltd.
Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Unresectable Locally Advanced/ Metastatic Adenocarcinoma of the Pancreas, Diseases [C] - Cancer [C04]
 
 
2018-002886-21: A Phase III randomized study evaluating gemcitabine and paclitaxel versus gemcitabine alone after FOLFIRINOX failure or intolerance in Metastatic Pancreatic Ductal Adenocarcinoma.

Not yet recruiting
3
210
Europe
Powder for concentrate for solution for infusion, Concentrate for solution for infusion
UNICANCER, Programme hospitalier de recherche clinique (PHRC)
Metastatic Pancreatic Ductal Adenocarcinoma, Advanced pancreas cancer, Diseases [C] - Cancer [C04]
 
 
AALL0932, NCT01190930 / 2011-003430-13: Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Active, not recruiting
3
9350
Europe, Canada, US, RoW
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, Bw 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Thioguanine, 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Aminopurine-6-thiol Hemihydrate, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Thioguanine Hemihydrate, Thioguanine Hydrate, Tioguanin, Tioguanine, Wellcome U3B, WR-1141, X 27, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
Children's Oncology Group, National Cancer Institute (NCI)
Acute Lymphoblastic Leukemia, Adult B Lymphoblastic Lymphoma, Ann Arbor Stage I B Lymphoblastic Lymphoma, Ann Arbor Stage II B Lymphoblastic Lymphoma, Childhood B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Lymphoblastic Lymphoma, Down Syndrome, Hypodiploid B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive
03/19
03/28
2019-001364-30: Randomized phase 3 trial comparing FOLFOX to gemcitabine in metastatic first-line in patients with pancreatic adenocarcinoma and non-fit for FOLFIRINOX

Not yet recruiting
3
400
Europe
Oxaliplatin, Folinic acid, 5-Fluorouracil, Gemcitabine, Solution for infusion, Powder for solution for infusion
Assistance Publique- Hôpitaux de Paris
Diseases [C] - Cancer [C04]
 
 
IDEA, NCT00958737 / 2009-010384-16: Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer

Active, not recruiting
3
2000
Europe
FOLFOX regimen, folinic acid, infusional fluorouracil, and oxaliplatin, CAPOX, capecitabine plus oxaliplatin; XELOX
GERCOR - Multidisciplinary Oncology Cooperative Group
Colorectal Cancer
01/20
12/23
2018-001728-20: Neoadjuvant Radiochemotherapy versus Chemotherapy for Patients with Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ). Neoadjuvante Radiochemotherapie versus Chemotherapie für Patienten mit lokal fortgeschrittenem, potentiell resektablen Adenokarzinom des ösophagogastralen Übergangs.

Not yet recruiting
3
340
Europe
5-Fluorouracil, Calcium Folinate, Oxaliplatin, Docetaxel, Solution for injection, Solution for solution for injection
Ruprecht-Karls-Universität Heidelberg, Deutsche Krebshilfe
Locally Advanced, Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ), Locally advanced resectable gastric cancer, Diseases [C] - Cancer [C04]
 
 
2018-000876-14: ACO/ARO/AIO-18.1: Short-course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined intermediate and high-risk rectal cancer patients A randomized phase III trial of the German Rectal Cancer Study Group

Not yet recruiting
3
702
Europe
5-fluorouracil, Oxaliplatin, Capecitabine, folinic acid, Solution for infusion, Concentrate for solution for infusion, Tablet
University Hospital Frankfurt, Goethe University, German Cancer Aid
Locally advanced rectal cancer (UICC stage II and III), Rectal cancer, Diseases [C] - Cancer [C04]
 
 
2019-000698-22: Olaparib +/- bevacizumab in CRC with SD/PR/CR from FOLFOX with bevacizumab.

Ongoing
3
525
Europe
Olaparib, MK-7339, Film-coated tablet, Concentrate for solution for infusion, Solution for injection/infusion, Avastin (Bevacizumab), 5-Fluorouracil-Ebewe (5-FU)
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc, Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc
The treatment of participants with unresectable or metastatic CRC that has not progressed following an induction course of FOLFOX + bevacizumab, Advanced Metastatic Colorectal Cancer (Has not progressed after completing at least 6 prior induction cycles of FOLFOX + Bevacizumab and can no longer tolerate any components of FOLFOX), Diseases [C] - Cancer [C04]
 
 
CALGB-80702, NCT01150045: Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Active, not recruiting
3
2527
Canada, US
celecoxib, 5-fluorouracil, placebo, oxaliplatin, leucovorin
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Colorectal Cancer
02/20
 
AALL1231, NCT02112916: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Active, not recruiting
3
847
Canada, US, RoW
Bortezomib, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid, LDP 341, LDP-341, LDP341, MLN 341, MLN-341, MLN341, PS 341, PS-341, PS341, Velcade, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Daunorubicin, Daunomycin, Daunorrubicina, DNR, Leukaemomycin C, Rubidomycin, Rubomycin C, Daunorubicin Hydrochloride, Cerubidin, Cerubidine, Cloridrato de Daunorubicina, Daunoblastin, Daunoblastina, Daunoblastine, Daunomycin Hydrochloride, Daunomycin, hydrochloride, Daunorubicin.HCl, Daunorubicini Hydrochloridum, FI-6339, Ondena, RP-13057, Rubidomycin Hydrochloride, Rubilem, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, LenaDex, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, FI106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Hydrocortisone Sodium Succinate, (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium Salt, A-Hydrocort, Buccalsone, Corlan, Cortisol Sodium Succinate, Cortop, Efcortelan, Emergent-EZ, Flebocortid, Hidroc Clora, Hycorace, Hydro-Adreson, Hydrocort, Hydrocortisone 21-Sodium Succinate, Hydrocortisone Na Succinate, Kinogen, Nordicort, Nositrol, Sinsurrene, Sodium hydrocortisone succinate, Solu-Cortef, Solu-Glyc, Ifosfamide, Asta Z 4942, Asta Z-4942, Cyfos, Holoxan, Holoxane, Ifex, IFO, IFO-Cell, Ifolem, Ifomida, Ifomide, Ifosfamidum, Ifoxan, IFX, Iphosphamid, Iphosphamide, Iso-Endoxan, Isoendoxan, Isophosphamide, Mitoxana, MJF 9325, MJF-9325, Naxamide, Seromida, Tronoxal, Z 4942, Z-4942, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, Bw 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Jylamvo, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Thioguanine, 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Aminopurine-6-thiol Hemihydrate, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Thioguanine Hemihydrate, Thioguanine Hydrate, Tioguanin, Tioguanine, Wellcome U3B, WR-1141, X 27, Vincristine, LCR, Leurocristine, VCR, Vincrystine, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma, Ann Arbor Stage III Adult Lymphoblastic Lymphoma, Ann Arbor Stage III Childhood Lymphoblastic Lymphoma, Ann Arbor Stage IV Adult Lymphoblastic Lymphoma, Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma, Childhood T Acute Lymphoblastic Leukemia
03/20
09/25
NCT03511963: A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC

Completed
3
677
RoW
HLX04 100 mg in 4 ml Injection, Avastin 100 mg in 4 ml Injection
Shanghai Henlius Biotech
Metastatic Colorectal Cancer (mCRC)
04/20
04/23
2020-000149-15: Combined chemotherapy and radiotherapy followed by planned surgery compared to combined chemotherapy and radiotherapy with surgery only when really needed, for patients with cancer in the esophagus.

Not yet recruiting
3
1020
Europe
Carboplatin, Paklitaxel, Cisplatin, 5-fluorouracil, Oxaliplatin, Calcium folinate, Concentrate for solution for infusion, Concentrate and solvent for solution for infusion, Solution for injection/infusion
Karolinska University Hospital, Karolinska University Hospital, Swedish Research Council
Resectable locally advanced squamous cell carcinoma (SCC) of the esophagus, Cancer in the gullet (esophagus), which is possible to operate., Diseases [C] - Cancer [C04]
 
 
CheckMate 649, NCT02872116 / 2016-001018-76: Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Checkmark Data from Checkmate-649 trial in advanced or metastatic gastric or gastroesophageal junction cancer at ASCO-GI 2023
Jan 2023 - Jan 2023: Data from Checkmate-649 trial in advanced or metastatic gastric or gastroesophageal junction cancer at ASCO-GI 2023
Checkmark From CheckMate-649 study in combination with chemo in the Chinese subgroup of adv/mets gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma
Apr 2021 - Apr 2021: From CheckMate-649 study in combination with chemo in the Chinese subgroup of adv/mets gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma
Checkmark Data from CheckMate 649 trial in combination with Yervoy for 1L gastric and esophageal cancers at ESMO 2020
More
Completed
3
2031
Europe, Canada, Japan, US, RoW
Nivolumab, Opdivo, BMS-936558, Ipilimumab, Yervoy, BMS-734016, Oxaliplatin, Capecitabine, Leucovorin, Fluorouracil
Bristol-Myers Squibb, Ono Pharmaceutical Co. Ltd
Gastric Cancer, Gastroesophageal Junction Cancer, Esophageal Adenocarcinoma
05/20
06/24
2020-002141-42: Addition of induction chemotherapy to the neoadjuvant treatment of patients with locally recurrent rectal cancer - the PelvEx II study Toevoeging van inductie chemotherapie aan de voorbehandeling van patiënten met lokaal teruggekeerde endeldarmkanker - de PelvEx II studie

Not yet recruiting
3
364
Europe
Capecitabine Accord, Oxaliplatin Accord, 5-Fluorouracil, Leucovorine Sandoz, Irinotecan, Infusion, Tablet, Oxaliplatin, Capecitabine, 5-fluorouracil, Leucovorin, Irinotecan
Catharina Hospital, Instituto Português de Oncologia de Lisboa Francisco Gentil – EPE, Catharina Ziekenhuis Eindhoven, ZonMW, ZonMw, Catharina Ziekenhuis Eindhoven
Locally recurrent rectal cancer Lokaal recidief rectum carcinoom, Locally recurrent rectal cancer Lokaal teruggekeerde endeldarmkanker, Diseases [C] - Cancer [C04]
 
 
2020-000613-32: This study is to understand how well an investigational drug (called Napabucasin) works when given in combination with a chemotherapy treatment for people with colorectal cancer after all available standard treatments.

Ongoing
3
668
Europe
Napabucasin, GB201, Capsule, Solution for injection, Solution for injection/infusion, Concentrate for solution for infusion, Bendafolin, 5-Flurouracil-Ebewe, Irinotecan Bendalis
1Globe Health Institute, 1Globe Health Institute
Histologically confirmed adenocarcinoma of the colon or rectum that is metastatic., Cancer of the colon or rectum., Diseases [C] - Cancer [C04]
 
 
2017-003832-35: Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction Type II/III adenocarcinoma – The phase III “PREVENT” trial of the AIO /CAOGI /ACO

Not yet recruiting
3
200
Europe
Docetaxel, Oxaliplatin, 5-fluorouracil, Leucovorin, Cisplatin, Concentrate for solution for infusion, Solution for injection
Institute of Clinical Cancer Research (IKF) Krankenhaus Nordwest, Deutsche Krebshilfe
locally advanced resectable diffuse type adenocarcinoma of the oesophagogastric junction or the stomach, locally advanced resectable diffuse type gastric cancer, Diseases [C] - Cancer [C04]
 
 
2018-001356-35: FOLFOX before surgey compared to risk-adapted chemotherapy after surgery in patients with locally advanced rectal cancer and low risk for local failure

Not yet recruiting
3
550
Europe
5-Fluorouracil, Oxaliplatin, Leucovorin, Capecitabin, Solution for injection, Concentrate and solvent for solution for infusion, Tablet, Oxaliplatin, Leucovorin, Capecitabin
University of Heidelberg, German Cancer Aid
Locally advanced rectal adenocarcinoma localized 0 - 16 cm from the anal verge with low risk of local failure, Locally advanced rectal cancer with low risk of local failure, Diseases [C] - Cancer [C04]
 
 
KL140-III-01, NCT03426371: Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

Recruiting
3
570
RoW
KL-140, Placebo
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Metastatic Colorectal Cancer
12/20
12/23
NCT03415763: Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

Recruiting
3
764
RoW
Capecitabine, Xeloda, mFOLFOX6 or CAPOX, 5-Fu-leucovorin-oxaliplatin or xeloda-oxaliplatin
LI XIN-XIANG
Rectal Neoplasms
12/20
12/25
RESPECT, UMIN000008866: Randomized Phase III Study of mFOLFOX7 or CAPOX plus Bevacizumab versus 5-Fluorouracil/Leucovorin or Capecitabine plus Bevacizumab as First-line Treatment in Elderly Patients with Metastatic Colorectal Cancer (JCOG1018, )

Active, not recruiting
3
250
Japan
capecitabine - Generic mfg., oxaliplatin - Generic mfg., Avastin (bevacizumab) - Roche, 5-fluorouracil - Generic mfg., leucovorin calcium - Generic mfg.
Japan Clinical Oncology Group (JCOG), National Cancer Center
Metastatic clorectal cancer
 
 
CONKO-007, NCT01827553 / 2009-014476-21: Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy

Completed
3
830
Europe
Induction chemotherapy with gemcitabine or FOLFIRINOX, all brands of gemcitabine and FOLFIRINOX components are allowed, Radiotherapy, 28 x 1.8 Gy, Chemotherapy, gemcitabine, all brands of gemcitabine are allowed, Chemotherapy with gemcitabine or FOLFIRINOX according to induction chemotherapy
University of Erlangen-Nürnberg Medical School
Pancreatic Cancer
02/21
11/23
KEYNOTE-177, NCT02563002 / 2015-002024-89: Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/)

Hourglass Jan 2021 - Dec 2021 : Overall survival data from KEYNOTE-177 trial for MSI-H 1L CRC
Checkmark From KEYNOTE-177 trial for DNA repair-deficient metastatic CRC at ESMO 2020
Sep 2020 - Sep 2020: From KEYNOTE-177 trial for DNA repair-deficient metastatic CRC at ESMO 2020
Checkmark Data from KEYNOTE-177 trial for metastatic colorectal cancer
May 2020 - May 2020: Data from KEYNOTE-177 trial for metastatic colorectal cancer
More
Completed
3
307
NA
mFOLFOX6, FOLFIRI, Pembrolizumab, MK-3475, SCH 900475, KEYTRUDA®, Bevacizumab, Cetuximab
Merck Sharp & Dohme LLC
Colorectal Carcinoma
02/21
07/23
2019-004582-40: TIming of start of systemIc treatment for asymptomatic MEtastasized PANcreatic cancer

Ongoing
3
184
Europe
Oxaliplatin, Leucovorin, Irinotecan, Fluorouracil, Paclitaxel, Gemcitabine, Concentrate for solution for infusion
Amsterdam UMC-Location AMC-dept. Internal Medicin, University of Amsterdam
Metastasized pancreatic cancer Gemetastaseerd pancreas carcinoom, Metastasized pancreatic cancer Uitgezaaide alvleesklierkanker, Diseases [C] - Cancer [C04]
 
 
2020-005078-82: Phase III study in patients with colorectal cancer RAS/BRAF un mutated on the tumor tissue and RAS mutated in liquid biopsy with the aim of comparing a FOLFIRI therapy in combination with cetuximab or bevacizumab. Studio di fase III in pazienti con diagnosi di tumore del colon-retto in presenza di RAS/BRAF non mutato sul tessuto del tumore e RAS mutato sulla biopsia liquida con l'obiettivo di confrontare una terapia con schema FOLFIRI in associazione al farmaco cetuximab o bevacizumab.

Not yet recruiting
3
280
Europe
Cetuximab, BEVACIZUMAB, [Cetuximab], [BEVACIZUMAB], Solution for infusion, Concentrate for solution for infusion, Erbitux, AVASTIN
AZIENDA OSPEDALIERA ARCISPEDALE SANTA MARIA NUOVA/IRCCS DI REGGIO EMILIA, AIFA - Italian Medicines Agency
Patients with metastatic colorectal cancer RAS/BRAF wild type not previously treated in metastatic setting Pazienti con tumore del colon-retto metastatico (mCRC)RAS/BRAF wild type non precedentemente trattati per malattia metastatica., Patients with mestatic colorectal cancer diagnosis with RAS/BRAF not mutated and never treated for metastatic disease Pazienti con diagnosi di tumore metastatico al colon-retto con RAS/BRAF non mutato mai trattati precedentemente per malattia mestatica, Diseases [C] - Cancer [C04]
 
 
OPTICAL, NCT02572141: FOLFOX or CAPOX Perioperative Chemotherapy Versus Postoperative Chemotherapy for Locally Advanced Colon Cancer

Active, not recruiting
3
738
RoW
Perioperative chemotherapy with mFOLFOX6 or CAPOX regimens, Oxaliplatin, 5-Fluorouracil, Capecitabine, Leucovorin, Postoperative chemotherapy with mFOLFOX6 or CAPOX regimens
Sun Yat-sen University
Colon Cancer
04/21
04/23
STRATEGIC-1, NCT01910610 / 2013-001928-19: Multi-Line Therapy Trial in Unresectable Metastatic Colorectal Cancer

Active, not recruiting
3
464
Europe, RoW
FOLFIRI-cetuximab, mFOLFOX6-bevacizumab, OPTIMOX-bevacizumab, irinotecan-based chemo + bevacizumab, Anti-EGFR agent (cetuximab +/- irinotecan or panitumumab), XELOX + bevacizumab
GERCOR - Multidisciplinary Oncology Cooperative Group, Hoffmann-La Roche
Colorectal Cancer Metastatic
07/23
12/24
2020-005141-16: Chemotherapy before or after surgery in patients with resectable pancreatic cancer: the PREOPANC-3 study.

Not yet recruiting
3
378
Europe
Leucovorin calcium, Fluorouracil, Irinotecan, Oxaliplatin, Powder for solution for injection/infusion, Solution for infusion, Concentrate for solution for infusion, LEUCOVORIN CALCIUM, Fluorouracil, Irinotecan, Oxaliplatin
Erasmus MC, Erasmus MC
non-metastatic resectable pancreatic cancer, non-metastatic resectable pancreatic cancer, Diseases [C] - Cancer [C04]
 
 
AALL1331, NCT02101853: Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia

Active, not recruiting
3
669
Canada, US, RoW
Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic, Allogeneic Hematopoietic Cell Transplantation, Allogeneic Stem Cell Transplantation, HSC, HSCT, Stem Cell Transplantation, Allogeneic, Asparaginase, ASP-1, Asparaginase II, Asparaginase-E.Coli, Colaspase, Elspar, Kidrolase, L-Asnase, L-ASP, L-Asparaginase, L-Asparagine Amidohydrolase, Laspar, Lcf-ASP, Leucogen, Leunase, MK-965, Paronal, Re-82-TAD-15, Serasa, Spectrila, Blinatumomab, AMG 103, AMG-103, AMG103, Anti-CD19 x Anti-CD3 Bispecific Monoclonal Antibody, Anti-CD19/Anti-CD3 Recombinant Bispecific Monoclonal Antibody MT103, Blincyto, MEDI 538, MEDI-538, MEDI538, MT 103, MT-103, MT103, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Asta B 518, B 518, B-518, B518, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR 138719, WR- 138719, WR-138719, WR138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycadron, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decadron DP, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasone Intensol, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Dxevo, Fluorodelta, Fortecortin, Gammacorten, Hemady, Hexadecadrol, Hexadrol, LenaDex, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, TaperDex, Visumetazone, ZoDex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP 16213, VP-16, VP-16-213, VP-16213, VP16, VP16213, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, Bw 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Jylamvo, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Mitoxantrone, Dihydroxyanthracenedione, Mitozantrone, Mitoxantrone Hydrochloride, CL 232315, DHAD, DHAQ, Dihydroxyanthracenedione Dihydrochloride, Mitoxantrone Dihydrochloride, Mitoxantroni Hydrochloridum, Mitozantrone Hydrochloride, Mitroxone, Neotalem, Novantrone, Onkotrone, Pralifan, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, Oncaspar-IV, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Pharmacological Study, Radiation Therapy, Cancer Radiotherapy, Energy Type, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Therapeutic Hydrocortisone, Aeroseb-HC, Barseb HC, Barseb-HC, Cetacort, Cort-Dome, Cortef, Cortenema, Cortifan, Cortisol, Cortispray, Cortril, Dermacort, Domolene, Eldecort, Hautosone, Heb-Cort, Hydrocortisone, Hydrocortone, Hytone, Komed-HC, Nutracort, Proctocort, Rectoid, Thioguanine, 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Aminopurine-6-thiol Hemihydrate, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Thioguanine Hemihydrate, Thioguanine Hydrate, Tioguanin, Tioguanine, Wellcome U3B, WR-1141, X 27, Vincristine, LCR, Leurocristine, VCR, Vincrystine, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
National Cancer Institute (NCI)
Recurrent B Acute Lymphoblastic Leukemia
06/21
09/25
AALL1131, NCT01406756 / 2014-001866-90: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

Recruiting
3
4895
US, Canada, Europe, RoW
Clofarabine, Clofarex, Clolar, Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Cytarabine, .beta.-Cytosine arabinoside, 1-.beta.-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-.beta.-D-Arabinofuranosylcytosine, 1-Beta-D-arabinofuranosyl-4-amino-2(1H)pyrimidinone, 1-Beta-D-arabinofuranosylcytosine, 1.beta.-D-Arabinofuranosylcytosine, 2(1H)-Pyrimidinone, 4-Amino-1-beta-D-arabinofuranosyl-, 2(1H)-Pyrimidinone, 4-amino-1.beta.-D-arabinofuranosyl-, Alexan, Ara-C, ARA-cell, Arabine, Arabinofuranosylcytosine, Arabinosylcytosine, Aracytidine, Aracytin, Aracytine, Beta-Cytosine Arabinoside, CHX-3311, Cytarabinum, Cytarbel, Cytosar, Cytosar-U, Cytosine Arabinoside, Cytosine-.beta.-arabinoside, Cytosine-beta-arabinoside, Erpalfa, Starasid, Tarabine PFS, U 19920, U-19920, Udicil, WR-28453, Dexamethasone, Aacidexam, Adexone, Aknichthol Dexa, Alba-Dex, Alin, Alin Depot, Alin Oftalmico, Amplidermis, Anemul mono, Auricularum, Auxiloson, Baycuten, Baycuten N, Cortidexason, Cortisumman, Decacort, Decadrol, Decadron, Decalix, Decameth, Decasone R.p., Dectancyl, Dekacort, Deltafluorene, Deronil, Desamethasone, Desameton, Dexa-Mamallet, Dexa-Rhinosan, Dexa-Scheroson, Dexa-sine, Dexacortal, Dexacortin, Dexafarma, Dexafluorene, Dexalocal, Dexamecortin, Dexameth, Dexamethasonum, Dexamonozon, Dexapos, Dexinoral, Dexone, Dinormon, Fluorodelta, Fortecortin, Gammacorten, Hexadecadrol, Hexadrol, Lokalison-F, Loverine, Methylfluorprednisolone, Millicorten, Mymethasone, Orgadrone, Spersadex, Visumetazone, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16-213, VP-16, VP-16-213, Hydrocortisone Sodium Succinate, (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium Salt, A-Hydrocort, Buccalsone, Corlan, Cortisol Sodium Succinate, Cortop, Efcortelan, Emergent-EZ, Flebocortid, Hidroc Clora, Hycorace, Hydro-Adreson, Hydrocort, Hydrocortisone 21-Sodium Succinate, Hydrocortisone Na Succinate, Kinogen, Nordicort, Nositrol, Sinsurrene, Sodium hydrocortisone succinate, Solu-Cortef, Solu-Glyc, Laboratory Biomarker Analysis, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Mercaptopurine, 3H-Purine-6-thiol, 6 MP, 6 Thiohypoxanthine, 6 Thiopurine, 6-Mercaptopurine, 6-Mercaptopurine Monohydrate, 6-MP, 6-Purinethiol, 6-Thiopurine, 6-Thioxopurine, 6H-Purine-6-thione, 1,7-dihydro- (9CI), 7-Mercapto-1,3,4,6-tetrazaindene, Alti-Mercaptopurine, Azathiopurine, BW 57-323H, Flocofil, Ismipur, Leukerin, Leupurin, Mercaleukim, Mercaleukin, Mercaptina, Mercaptopurinum, Mercapurin, Mern, NCI-C04886, Puri-Nethol, Purimethol, Purine, 6-mercapto-, Purine-6-thiol (8CI), Purine-6-thiol, monohydrate, Purinethiol, Purinethol, U-4748, WR-2785, Methotrexate, Abitrexate, Alpha-Methopterin, Amethopterin, Brimexate, CL 14377, CL-14377, Emtexate, Emthexat, Emthexate, Farmitrexat, Fauldexato, Folex, Folex PFS, Lantarel, Ledertrexate, Lumexon, Maxtrex, Medsatrexate, Metex, Methoblastin, Methotrexate LPF, Methotrexate Methylaminopterin, Methotrexatum, Metotrexato, Metrotex, Mexate, Mexate-AQ, MTX, Novatrex, Rheumatrex, Texate, Tremetex, Trexeron, Trixilem, WR-19039, Pegaspargase, L-Asparaginase with Polyethylene Glycol, Oncaspar, PEG-Asparaginase, PEG-L-Asparaginase, PEG-L-Asparaginase (Enzon - Kyowa Hakko), PEGLA, Polyethylene Glycol L-Asparaginase, Polyethylene Glycol-L-Asparaginase, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisonum, Prednitone, Promifen, Servisone, SK-Prednisone, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, RADIATION, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Thioguanine, 2-Amino 6MP, 2-Amino-1,7-dihydro-6H-purine-6-thione, 2-Amino-6-mercaptopurine, 2-Amino-6-purinethiol, 2-Aminopurin-6-thiol, 2-Aminopurine-6(1H)-thione, 2-Aminopurine-6-thiol, 2-Mercapto-6-aminopurine, 6-Amino-2-mercaptopurine, 6-Mercapto-2-aminopurine, 6-Mercaptoguanine, 6-TG, 6H-Purine-6-thione, 2-amino-1,7-dihydro- (9CI), BW 5071, Lanvis, Tabloid, Tioguanin, Tioguanine, Wellcome U3B, WR-1141, X 27, Vincristine Sulfate, Kyocristine, Leurocristine Sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
Children's Oncology Group, National Cancer Institute (NCI)
B Acute Lymphoblastic Leukemia, Bone Necrosis, Central Nervous System Leukemia, Cognitive Side Effects of Cancer Therapy, Neurotoxicity Syndrome, Pain, Testicular Leukemia, Therapy-Related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
08/21
 
2021-000317-17: Survival analysis after pre-surgical therapy in patients with resectable pancreatic cancer and risk factors ANÁLISIS DE SUPERVIVENCIA TRAS TRATAMIENTO ANTES DE LA CIRUGÍA EN CÁNCER DE PÁNCREAS RESECABLE CON FACTORES DE RIESGO

Ongoing
3
116
Europe
Irinotecan, Fluorouracil, Oxaliplatin, calcium folinate, Concentrate for solution for injection/infusion, Solution for infusion
Fundación para la Gestión de la Investigación Biomédica de Cádiz-INIBICA, Instituto de Salud Carlos III
Resectable pancreatic cancer and risk factors Cáncer de pancreas resecable con factores de riesgo, Non-operable pancreatic cancer plus other conditions that increase the possibility to adquire a disease Cancer de pancreas no operable mas otras condiciones que aumenten la posibilidad de adquirir una enfermedad, Diseases [C] - Cancer [C04]
 
 
2020-006144-18: Prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of active post-resection/ablation therapy in patients with metastatic colorectal cancer Prospektive, randomisierte, offene, multizentrische Phase III Studie zur Untersuchung der Wirksamkeit einer Therapie in Patienten mit metastasiertem kolorektalen Karzinom, nach erfolgter Resektion oder Ablation

Not yet recruiting
3
507
Europe
5-Fluorouracil, Oxaliplatin, Leucovorin, Irinotecan, Solution for solution for injection, Concentrate and solvent for solution for infusion, Solution for injection, Concentrate for solution for infusion, Oxaliplatin, Leucovorin
Charité Universitätsmedizin Berlin, DFG - Deutsche Forschungsgemeinschaft e.V.
Metastatic colorectal cancer after definite interventional therapy of all lesions, Metastatic colorectal cancer after therapy of lesions, Diseases [C] - Cancer [C04]
 
 
2020-004906-79: A study to evaluate the efficacy of oxaliplatin- or gemcitabine-based chemotherapy after allocation by standard criteria or by genetic markers in patients with resected pancreatic carcinoma Studie zur Wirksamkeit einer Chemotherapie nach Operation beim Karzinom der Bauchspeicheldrüse, wobei die Zuteilung zur Oxaliplatin-basierten oder Gemcitabin-basierten Chemotherapie entweder nach klinischen Standardkriterien oder nach genetischen Markern erfolgt

Not yet recruiting
3
394
Europe
Gemcitabine, Capecitabine, 5-fluorouracil, Irinotecan, Calcium Folinate, Oxaliplatin, Powder for solution for infusion, Film-coated tablet, Solution for injection, Concentrate for solution for infusion, Solution for injection/infusion
Ruprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg, Dietmar Hopp Stiftung, Cancerforskningsfonden i Norrland
Resected pancreatic ductal adenocarcinoma operiertes duktales Pankreas-Adenokarzinom, Resected pancreatic ductal adenocarcinoma operiertes duktales Bauchspeicheldrüsen-Adenokarzinom, Diseases [C] - Cancer [C04]
 
 
APEC, NCT02965248: Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer ( Study)

Recruiting
3
147
RoW
Standard adjuvant systemic chemotherapy, adjuvant oxaliplatin, 5-FU, and leucovorin calcium (mFOLFOX6), adjuvant oxaliplatin and capecitabine (CapeOx), adjuvant 5-FU and leucovorin calcium (sLV5FU2), adjuvant capecitabine (Cape), Hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed, Intraperitoneal raltitrexed 3 mg/m2, Hyperthermic intraperitoneal chemotherapy (HIPEC) with oxaliplatin, I.V. leucovorin calcium 20 mg/m2, I.V. 5-FU 400 mg/m2, Intraperitoneal oxaliplatin 130 mg/m2
Fudan University
Locally Advanced Colorectal Cancer
11/21
11/23
NCT05074589: Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer

Completed
3
298
RoW
Irinotecan liposome、5-Fluorouracil、Leucovorin, Placebo、5-Fluorouracil、Leucovorin
Jiangsu HengRui Medicine Co., Ltd.
Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy
11/21
03/22
NCT02087475: Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Recruiting
3
360
RoW
Irinotecan, 5-fluorouracil, Local radiotherapy, R0 resection
Sixth Affiliated Hospital, Sun Yat-sen University
Colorectal Neoplasms, Effects of Chemotherapy, Surgery, Metastasis, Local Neoplasm Recurrence
12/21
12/24
ARMANI, NCT02934464: Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers

Recruiting
3
280
Europe
RAMUCIRUMAB, Cyramza, Paclitaxel, FOLFOX 4, Oxaliplatino + l-leucovorin + 5 Fluorouracile, mFOLFOX 6, XELOX, Oxaliplatino + Capecitabina
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Stomach Neoplasms
12/21
12/21
FNF-014, NCT03788226: A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer

Recruiting
3
600
RoW
POF, CAPOX/SOX/FOLFOX
Fujian Cancer Hospital
Gastric Cancer Stage III
12/21
12/23
NCT04303429: Adjuvant Chemotherapy in High Risk Stage II Colon Cancer

Not yet recruiting
3
962
NA
FOLFOX/XELOX/Capecitabine
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Stage II Colon Cancer, Adjuvant Chemotherapy
01/22
01/25
NEOPAN, NCT02539537 / 2014-003510-82: A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma

Completed
3
171
Europe
Gemcitabine, Folinic Acid, 5-Fluoro-uracil, Oxaliplatin, Irinotecan, L-folinic
UNICANCER
Pancreatic Cancer, Carcinoma
02/22
09/23
ChiCTR2000037406: A prospective, randomized, controlled trial comparing adjuvant therapy after hepatectomy and pure hepatectomy in colorectal cancer liver metastasis patients with low-risk of recurrence

Not yet recruiting
3
546
 
Adjuvant chemotherapy FOLFOX, CapeOX, or Xeloda single drug ;none
Shanghai Cancer Center, Fudan University; shanghai Cancer Center, Fudan University, none
colorectal cancer liver metastasis
 
 
NCT03206151: CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer

Completed
3
520
RoW
CMAB009, Eribitux, Irinotecan, Camptosar, Folinic acid, leucovorin, 5-fluorouracil, Fluoroplex
Taizhou Mabtech Pharmaceutical Co.,Ltd
Metastatic Colorectal Cancer
05/22
05/22
NAPOLI-3, NCT04083235 / 2018-003585-14: A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment

Completed
3
770
Europe, Canada, US, RoW
Irinotecan Liposomal Injection, Onivyde®, Nal-IRI, Oxaliplatin, Eloxatin®, 5Fluorouracil, Adrucil®, flurouracil, 5-FU, Leucovorin, Folinic Acid, Nab-paclitaxel, Abraxane®, Gemcitabine, Gemzar®
Ipsen
Metastatic Adenocarcinoma of the Pancreas
07/22
02/25
CAIRO5, NCT02162563 / 2013-005435-24: Treatment Strategies in Colorectal Cancer Patients with Initially Unresectable Liver-only Metastases

Completed
3
530
Europe
FOLFOX/ FOLFIRI with bevacizumab, - bevacizumab, - irinotecan, - leucovorin, - 5-fluorouracil, - oxaliplatin, FOLFOXIRI with bevacizumab, FOLFOX/ FOLFIRI with panitumumab, - panitumumab
Dutch Colorectal Cancer Group
Colorectal Cancer, Liver Metastases
07/22
01/25
NCT04516681: Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

Recruiting
3
400
RoW
Ascorbic acid, Vitamin C, FOLFOX Protocol, FOLFOX+/- bevacizumab, Adebrelimab
Fudan University
Colorectal Cancer, Vitamin C, GLUT3
12/25
12/25
Spotlight, NCT03504397 / 2017-002567-17: A Phase 3 Efficacy, Safety and Tolerability Study of Zolbetuximab (Experimental Drug) Plus mFOLFOX6 Chemotherapy Compared to Placebo Plus mFOLFOX6 as Treatment for Gastric and Gastroesophageal Junction (GEJ) Cancer

Apr 2023 - Mar 2024: Submission in Japan for gastric/gastroesophageal junction cancer
Apr 2023 - Sep 2023: BLA submission for gastric or gastroesophageal junction adenocarcinoma (based on GLOW trial)
Apr 2023 - Sep 2023: BLA submission for gastric or gastroesophageal junction adenocarcinoma (based on Spotlight trial) in combination with mFOLFOX6 chemotherapy
Checkmark Data from SPOTLIGHT trial in combination with mFOLFOX6 chemotherapy for gastric/gastroesophageal junction cancer
Dec 2022 - Dec 2022: Data from SPOTLIGHT trial in combination with mFOLFOX6 chemotherapy for gastric/gastroesophageal junction cancer
Active, not recruiting
3
565
Europe, Canada, Japan, US, RoW
zolbetuximab, IMAB362, placebo, oxaliplatin, folinic acid, fluorouracil
Astellas Pharma Global Development, Inc.
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
09/22
03/25
NCT04525326: Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Not yet recruiting
3
584
NA
Cetuximab, Bevacizumab, mFOLFOX/FOLFIRI ( Standard Chemotherapy)
Fudan University
Colorectal Cancer, Liver Metastases
10/22
11/22
 

Download Options